Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04799028
Other study ID # 20.10.INF
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 19, 2021
Est. completion date October 28, 2022

Study information

Verified date March 2023
Source Société des Produits Nestlé (SPN)
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the effects of experimental growing up milk (EXPL) as compared to traditional children's fortified milk (CTRL) fed for 6 months on bone mass index.


Description:

A randomized, double-blind controlled clinical trial was chosen to study the effects of toddler milk containing L. reuteri and GOS (4g/L) and a low sn-1, -3 fat blend when compared to a control formula. There is an additional unblinded habitual intake reference group (REF) for "real-world" comparison (including 58% non-dairy drinkers according to observational data).


Recruitment information / eligibility

Status Completed
Enrollment 273
Est. completion date October 28, 2022
Est. primary completion date August 16, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 2 Years to 3 Years
Eligibility All subjects must comply with all the following criteria: 1. Written informed consent has been obtained from the parent(s)/legally acceptable representative (LAR). 2. Singleton, full-term gestational birth (= 37 completed weeks of gestation), with a birth weight of = 2.5 kg and = 4.5 kg. 3. Child is between 24 months ±1 week to 36 months ±1 week. 4. Child is not currently consuming nor has consumed any formulas or taking any supplements with pre- or probiotics at enrolment or in the past month. 5. Child's parent(s)/guardian is of legal age of consent, must understand the informed consent and other study documents, and is willing and able to fulfill the requirements of the study protocol. All subjects presenting one or more of the following criteria are excluded from participation in the study: 1. Chronic infectious, metabolic, genetic illness or other disease including any condition that impacts feeding or growth. 2. History of bone, malabsorption, metabolic, congenital or chromosomal abnormality known to affect feeding or growth. 3. Use of systemic antibiotics or anti-mycotic medication in the 4 weeks preceding enrollment. 4. Known or suspected cows' milk protein intolerance / allergy, or lactose intolerance, or severe food allergies that impact diet. 5. Current breast milk feeding in place of all other milk, and/or milk alternatives. 6. Clinical signs of severe micronutrient deficiencies. 7. Parents not willing / not able to comply with the requirements of study protocol. 8. Child's participation in another interventional clinical trial.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Traditional cow's milk
Fortified cow's milk
Experimental milk
Milk with synbiotics and fat blend
Habitual diet
Habitual diet

Locations

Country Name City State
Philippines Asian Foundation for Tropical Medicine, Inc. Muntinlupa

Sponsors (1)

Lead Sponsor Collaborator
Société des Produits Nestlé (SPN)

Country where clinical trial is conducted

Philippines, 

Outcome

Type Measure Description Time frame Safety issue
Other Anthropometry Measurement of weight Day 1, Day 180
Other Anthropometry Measurement of height Day 1, Day 180
Other Anthropometry Measurement of head circumference Day 1, Day 180
Other Safety endpoints Standard AEs reporting for safety assessment Day 1, Day 180 and follow up of 14 days after last intake of study products
Primary Speed of sound (SOS) Speed of sound (SOS) using a quantitative ultrasound methods measured by Pediatric Sunlight 9000 device Day 1, Day 90, Day 180
Secondary GI tolerance and stooling patterns Stool patterns including stool frequency will be recorded retrospectively via 24-hour GI Symptom and Behavior Recall Day 1
Secondary GI tolerance and stooling patterns Stool patterns including stool consistency will be recorded retrospectively via 24-hour GI Symptom and Behavior Recall Day 1
Secondary GI tolerance and stooling patterns Stool patterns including stool frequency will be recorded using 3-day GI Symptom and Behavior diary Day 90, Day 180
Secondary GI tolerance and stooling patterns Stool patterns including stool consistency will be recorded using 3-day GI Symptom and Behavior diary Day 90, Day 180
Secondary GI tolerance and stooling patterns Parent perceptions of GI symptoms using parent-reported questionnaire Toddler Gut Comfort Questionnaire (GCQ) using VAS from 1-Never to 6-Always with higher scores indicating increasing GI burden. Day 1, Day 90, Day 180
Secondary GI tolerance and stooling patterns Parent perceptions of GI-related behaviors using parent-reported questionnaire Toddler Gut Comfort Questionnaire (GCQ) using VAS from 1-Never to 6-Always with higher scores indicating increasing GI burden. Day 1, Day 90, Day 180
Secondary Stool analyses Excretion of fecal calcium fatty acid soaps Day 1, Day 180
Secondary Stool analyses Measurement of stool calcium content Day 1, Day 180
Secondary Serum vitamin D Measured by serum 25[OH]D concentration requiring 1mL of whole blood sample. Day 1, Day 180
Secondary Urine and Blood bone turnover markers Bone accretion markers in urinary [C-terminal cross-linked telopeptides of type I collagen (CTX) Day 1, Day 180 (EXPL and CTRL groups only)
Secondary Urine and Blood bone turnover markers serum procollagen type I N-terminal propeptide (PINP) Day 1, Day 180 (EXPL and CTRL groups only
Secondary Gut microbiota Gut microbiota analyzed for microbiome composition and diversity using next generation shotgun metagenomics sequencing, requiring 3g of stool sample. Day 1, Day 180
Secondary Stool analyses Determination of fecal short chain fatty acids (SCFAs) Day 1, Day 180
Secondary Stool analyses Fecal pH and metabolism. Day 1, Day 180
Secondary Stool analyses Fecal markers of gut health Day 1, Day 180
Secondary Physical strength Hand grip test (Jamar hand dynamometer) tailored for toddlers will be used as previously described Bohannon et al Pediatric Physical Therapy 2017. Day 1, Day 180
Secondary Vitamin B serum vitamin B concentration requiring 2 mL of whole blood sample. Day 1, Day 180
Secondary Dietary intake patterns Intake patterns are assessed using parent-reported questionnaire Child Eating Behavior Questionnaire including variety of food groups consumed as well as behaviors rated from Never to Always. Day 1, Day 180
Secondary Child quality of life using validated ITQOL SF-47 questionnaire assessed using the parent-reported questionnaires Day 1, Day 180
Secondary Outdoor Playtime Assessed using parent-reported questionnaire on Outdoor Playtime recording number of hours child spent outside. Day 1 and Day 180
Secondary Child temperament Children's Behavior Questionnaire (very short form), consisting of 36 questions and 3 scales on child temperament domains Surgency, Negative Affect and Effort Control with each question ranging 1-extremely untrue to 7- extremely true of parent observing various behaviors. Day 1, Day 180